Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland

A.S. Ciblis; M.L. Butler; L.W. Bokde; P.G. Mullins; D. O'Neill; J.P. McNulty

doi:10.1016/j.dadm.2014.11.011

Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland

A.S. Ciblis
, M.L. Butler
, L.W. Bokde
, P.G. Mullins
, D. O'Neill
, J.P. McNulty

European Regional Development Fund

Research output: Contribution to journal › Article › peer-review

170 Downloads (Pure)

Abstract

Background: Neuroimaging is an increasingly important tool in the diagnostic workup of dementia. Neurologists, geriatricians, and old-age psychiatrists are involved in key tasks in the diagnostic process, frequently referring patients with suspected dementia for neuroimaging. Methods: The research design was a postal survey of all geriatricians, old-age psychiatrists, and neurologists in the Republic of Ireland (N5176) as identified by the Irish Medical Directory 2011–2012 and supplementary listings. Results: Almost 65% of specialists did not have access to 2-[18F]fluoro-2-deoxy-D-glucose positron emission (FDG-PET) or FDG-PET/computed tomography (CT), and 80.3% did not have access to perfusion hexamethylpropyleneamine oxime single-photon emission computed tomography (SPECT) or dopaminergic iodine-123-radiolabeled 2b-carbomethoxy-3b-(4-iodophenyl)-N- (3-fluoropropyl) nortropane SPECT. Most specialists (88.7%) referred patients with mild cognitive impairment or suspected dementia for magnetic resonance imaging (MRI), 81.7% referred for CT, and 26.8% for FDG-PET or FDG-PET/CT. Only 44.6% of respondents were aware of dementiaspecific protocols for referrals for neuroimaging. Conclusion: Specialist access to imaging modalities other than CT and MRI is restricted. Improved access may affect patient treatment and care..

Original language	English
Pages (from-to)	41-47
Journal	Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Volume	1
Issue number	1
DOIs	https://doi.org/10.1016/j.dadm.2014.11.011
Publication status	Published - 29 Mar 2015

Access to Document

10.1016/j.dadm.2014.11.011Licence: CC BY-NC-ND

PDB3700-00.pdfFinal published version, 444 KBLicence: CC BY-NC-ND

Bangor Imaging UNit - 3 T MRI scanner
Mullins, P. (Manager), Binney, R. (Other), Bestelmeyer, P. (Other), Downing, P. (Other), Kornysheva, E. (Other), Valyear, K. (Other), Koldewyn, K. (Other), Ramsey, R. (Other), d'Avossa, G. (Other), Carey, D. (Other), Henderson, R. (Other), Rossetti, G. (Other), Oliver, S. (Other) & Macdonald, J. (Other)
Facility/equipment: Facility

Cite this

@article{b555e4da1d0d486fbd9cd2c475692f91,

title = "Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland",

abstract = "Background: Neuroimaging is an increasingly important tool in the diagnostic workup of dementia. Neurologists, geriatricians, and old-age psychiatrists are involved in key tasks in the diagnostic process, frequently referring patients with suspected dementia for neuroimaging. Methods: The research design was a postal survey of all geriatricians, old-age psychiatrists, and neurologists in the Republic of Ireland (N5176) as identified by the Irish Medical Directory 2011–2012 and supplementary listings. Results: Almost 65\% of specialists did not have access to 2-[18F]fluoro-2-deoxy-D-glucose positron emission (FDG-PET) or FDG-PET/computed tomography (CT), and 80.3\% did not have access to perfusion hexamethylpropyleneamine oxime single-photon emission computed tomography (SPECT) or dopaminergic iodine-123-radiolabeled 2b-carbomethoxy-3b-(4-iodophenyl)-N- (3-fluoropropyl) nortropane SPECT. Most specialists (88.7\%) referred patients with mild cognitive impairment or suspected dementia for magnetic resonance imaging (MRI), 81.7\% referred for CT, and 26.8\% for FDG-PET or FDG-PET/CT. Only 44.6\% of respondents were aware of dementiaspecific protocols for referrals for neuroimaging. Conclusion: Specialist access to imaging modalities other than CT and MRI is restricted. Improved access may affect patient treatment and care..",

author = "A.S. Ciblis and M.L. Butler and L.W. Bokde and P.G. Mullins and D. O'Neill and J.P. McNulty",

year = "2015",

month = mar,

day = "29",

doi = "10.1016/j.dadm.2014.11.011",

language = "English",

volume = "1",

pages = "41--47",

journal = "Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring",

issn = "2352-8729",

publisher = "John Wiley and Sons Inc",

number = "1",

}

TY - JOUR

T1 - Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland

AU - Ciblis, A.S.

AU - Butler, M.L.

AU - Bokde, L.W.

AU - Mullins, P.G.

AU - O'Neill, D.

AU - McNulty, J.P.

PY - 2015/3/29

Y1 - 2015/3/29

N2 - Background: Neuroimaging is an increasingly important tool in the diagnostic workup of dementia. Neurologists, geriatricians, and old-age psychiatrists are involved in key tasks in the diagnostic process, frequently referring patients with suspected dementia for neuroimaging. Methods: The research design was a postal survey of all geriatricians, old-age psychiatrists, and neurologists in the Republic of Ireland (N5176) as identified by the Irish Medical Directory 2011–2012 and supplementary listings. Results: Almost 65% of specialists did not have access to 2-[18F]fluoro-2-deoxy-D-glucose positron emission (FDG-PET) or FDG-PET/computed tomography (CT), and 80.3% did not have access to perfusion hexamethylpropyleneamine oxime single-photon emission computed tomography (SPECT) or dopaminergic iodine-123-radiolabeled 2b-carbomethoxy-3b-(4-iodophenyl)-N- (3-fluoropropyl) nortropane SPECT. Most specialists (88.7%) referred patients with mild cognitive impairment or suspected dementia for magnetic resonance imaging (MRI), 81.7% referred for CT, and 26.8% for FDG-PET or FDG-PET/CT. Only 44.6% of respondents were aware of dementiaspecific protocols for referrals for neuroimaging. Conclusion: Specialist access to imaging modalities other than CT and MRI is restricted. Improved access may affect patient treatment and care..

AB - Background: Neuroimaging is an increasingly important tool in the diagnostic workup of dementia. Neurologists, geriatricians, and old-age psychiatrists are involved in key tasks in the diagnostic process, frequently referring patients with suspected dementia for neuroimaging. Methods: The research design was a postal survey of all geriatricians, old-age psychiatrists, and neurologists in the Republic of Ireland (N5176) as identified by the Irish Medical Directory 2011–2012 and supplementary listings. Results: Almost 65% of specialists did not have access to 2-[18F]fluoro-2-deoxy-D-glucose positron emission (FDG-PET) or FDG-PET/computed tomography (CT), and 80.3% did not have access to perfusion hexamethylpropyleneamine oxime single-photon emission computed tomography (SPECT) or dopaminergic iodine-123-radiolabeled 2b-carbomethoxy-3b-(4-iodophenyl)-N- (3-fluoropropyl) nortropane SPECT. Most specialists (88.7%) referred patients with mild cognitive impairment or suspected dementia for magnetic resonance imaging (MRI), 81.7% referred for CT, and 26.8% for FDG-PET or FDG-PET/CT. Only 44.6% of respondents were aware of dementiaspecific protocols for referrals for neuroimaging. Conclusion: Specialist access to imaging modalities other than CT and MRI is restricted. Improved access may affect patient treatment and care..

U2 - 10.1016/j.dadm.2014.11.011

DO - 10.1016/j.dadm.2014.11.011

M3 - Article

SN - 2352-8729

VL - 1

SP - 41

EP - 47

JO - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

JF - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

IS - 1

ER -

Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland

Abstract

Access to Document

Fingerprint

Equipment

Bangor Imaging UNit - 3 T MRI scanner

Cite this